Thought for the Day is the most surprising success story in intelligent broadcasting. It ought not to work, but it does. On one level it feels like the sort of thing that should have died out circa ...
Quality-adjusted time without symptoms or toxicity (Q-TWiST) of patients with metastatic colorectal cancer (mCRC) treated with fruquintinib in a phase II clinical trial. This is an ASCO Meeting ...
Clips from Thought for the Day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results